Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14847 total
ImmunityBio heads into October with an unusual split: short conviction remains historically high while the borrow market has quietly eased, creating a setup worth watching ahead of a November earnings date. The short…
Roland Corporation enters the final day of September with a quiet but consistent downward drift, off 2.1% on the week and 2.6% over the past month to close at JPY 3,675, setting up an unremarkable run into its November…
Ondas Inc. ends September with its short position near a month-long high, the borrow market still fully exhausted, and the options market finally pulling back from its most defensive extreme of the year. The most…
QVCG has fallen another 11% this week to $14.14, pushing GoldenTree Asset Management further into the red on a position it has been actively adding to — and the gap between activist conviction and market reality is…
Vivmark Residential enters the final week of September with an unusual split: options traders are suddenly much more defensive than they have been all year, even as short sellers have been cutting exposure at a notable…
AIIR enters the final week of September caught between a stock that keeps climbing and a borrow market that keeps tightening — an unusual combination that deserves attention from anyone watching this name. The lending…
EROC enters the final week of September with a striking contradiction at its core: short sellers have roughly doubled their positions in a month, yet an activist investor holding a 78% Schedule 13D stake sits at the…
Lincoln International enters the final week of September under noticeable pressure, having shed more than 10% over the past five trading days to close at $23.37 — even as Friday delivered a modest 1% bounce. The most…
AADX enters the final week of September with a striking and sudden shift in short positioning — one of the sharpest weekly build-ups the stock has seen since its NYSE debut. The headline number is hard to ignore: short…
Liftoff Mobile enters the final week of September with a striking build in short positions against a stock already down 15% in a month — and an activist investor on the register with a Schedule 13D stake. The short…
FPT Corporation has shed nearly 10% in seven days, pulling the stock to its lowest level in months, even as analysts see meaningful upside from current prices. The price action is the week's defining story. FPT closed…
Forbright, Inc. has drawn a sudden wave of short-selling interest since its mid-September listing, even as the borrow market remains wide open and the analyst community is broadly constructive. The most striking…
INDOMIM closed Thursday down 2.7% to ₹1,275.95, a single-day slip that does little to dent a 43% one-month rally — but the ownership dynamics beneath that move deserve closer attention than the headline return…
DIGIS has found some footing this week — up 1.6% on Friday to €6.47 — but the month remains firmly in the red, down over 8%, and the lending market that swung so dramatically in early September is now settling into a…
INFRAC enters the final stretch of September with its most distinctive feature unchanged: every insider transaction on record is a buy, and that streak extended again this week. The boardroom accumulation pattern at…
VIV heads into the final week of September with the stock down nearly 3% on the week, options positioning quietly turning more cautious, and a next earnings date of October 27 already drawing attention from…
People Incorporated surged 11% Thursday, turning a sustained short-selling campaign into an uncomfortable ride for bears — while options traders remain firmly on the other side of the trade. The stock closed at $40.00…
Intellia Therapeutics heads into the final week of September with a striking contradiction at its core: nearly 40% of the float is shorted, yet options traders are the most bullish they have been all year. Short…
MOL heads into the final week of September with an unusual insider dynamic: a board director just made a sizeable open-market purchase even as other executives were selling — and the stock sits barely flat on the week…
A small but timely insider sale has added a new data point to HBMN's setup, arriving just as the stock heads into its October 23 half-year results with a 3.4% weekly loss still on the books. On September 24, a related…
